Skip to main content
. 2014 Feb 12;8(3):269–286. doi: 10.1007/s12105-014-0527-7

Table 4.

Clinical characteristics for current patient series

# Age, race, sex Side and site Previous history Duration and symptoms Size; stage Diagnosis, grade, HPV Treatment Outcome
1 38 B F L; NC, E, P N 70 mo; sinusitis, vertigo and migraine 3.5 cm; III Inverted, SCC, grade 3, HPV− Resection; 60 Gy A, NED, no recurrences, 6.3 year
2 62 W M L; NC N 4 mo; sinusitis, obstruction 5 cm; III Inverted, SNUC, grade 3, HPV− Wide resection; 70 Gy and chemotherapy A, NED, no recurrences, 6.5 year
3 72 B F R; Ma Y: 17 mo before 5 mo; mass, obstruction, discharge and serous otitis 7.5 cm; III Inverted, SCC, grade 3, HPV− Medial maxillectomy A, NED, no recurrences, 4.4 year
4 46 B M Bi; NC, NP Y: 7 mo before 6 mo; mass, obstruction, epistaxis, hearing loss 4 cm; IVA Inverted, SCC, grade 3, HPV−, LN+ FESS; 70 Gy; chemotherapy A, NED, no recurrences, 4.3 year
5 55 W M L; NC, NP, Mastoid Y: 4 recurrences, with 42 mo from 1st diagnosis to carcinoma 300 mo; mass and hearing loss 4 cm; IVA Inverted, SCC, grade 2, HPV+ Exenteration; 66 Gy; chemotherapy A; L, local recurrence with surgery, 3.5 year
6 72 W M R; Ma N 10 mo; mass, pain, discharge, epistaxis, polyps, sinusitis, transient diplopia and periorbital swelling 2.9 cm; II Inverted, Mucoepidermoid carcinoma, grade 3, HPV− Wide resection (including Caldwell Luc), 60 Gy D, L, local recurrence to skull base, with surgery, 2.4 year
7 50 W F L; NC (septum) N 8 mo; mass, occasional sore throat and hoarseness 3 cm; I Exophytic, SCC, grade 2, HPV− FESS; radiation (unknown total dose) A, NED, no recurrences; 1.9 year
8 58 W M R; NC; S; skull base N 27; discharge, obstruction and sinusitis 5 cm; IVA Inverted; SCC, grade 3, HPV− FESS; 66 Gy A, NED, no recurrences; 1.1 year
9 70 W F Bi; Ma Y: 2 recurrences, with 62 mo from 1st diagnosis to carcinoma 5 mo; mass, epistaxis 2 cm; 0 Inverted; carcinoma in situ, grade 1, HPV− FESS A, L, recurrence 8 months after primary, treated by surgery, 1 year
10 54 W M R; NC (septum) N 6 mo; obstruction 3.0 cm; II Exophytic, SCC, grade 3, HPV+ FESS A, L, incomplete excision with local disease remaining; 1.0 year
11 46 W M R; NC; Ma; E, NP N 4 mo; mass, pain, epistaxis, difficulty breathing, weight loss 3.0 cm; IVA Inverted, SCC, grade 2, HPV+ Wide excision; radiation on-going; chemotherapy A, L, disease is still present; 0.3 year
12 50 W M Bi; NC; S, ear N 120 mo; mass, sinusitis, hearing loss, tinnitus 5.4 cm; IVA Inverted, SCC, grade 2, HPV+ Wide resection; 60 Gy; chemotherapy A, NED, no recurrences, 0.4 year
13 76 W F R; NC; E; S N 2 mo; mass, epistaxis, sinusitis, obstruction 3.7 cm; III Inverted; SCC in situ, grade I, HPV−, LN+ FESS; lymph node dissection A, NED, but only 0.3 year
14 79 W M R; Ma Y: 9.8 mo before 8 mo; mass, obstruction 5.3 cm; III Inverted, SCC, grade 2, HPV− Wide resection A, NED, no recurrences, but only 0.3 years
15 74 F R; Ma N 1 mo; mass 5.5 cm; IVA Inverted, SCC, grade 1, HPV− Wide resection Lost to follow-up
16 86 F L; E N 2 weeks; discharge and diplopia 6 cm; III Inverted, SCC, grade 1, HPV− Resection; radiation and chemotherapy A, NED, no recurrences, 1.6 year
17 63 W M Bi; NC; E N 120 mo; mass, polyps and headache 5 cm; IVA Inverted, SCC, grade 3, HPV− Wide resection; radiation and chemotherapy A, NED, no recurrence, but only 0.3 year
18 60 W M L; Ma; E N unknown symptoms 3.5 cm; III Inverted, SCC, grade 1, HPV− Wide resection A, NED, no recurrences, 5.2 year
19 50 W M Bi; NC; Ma Y: 73 mo before 24 mo; polyps 2.7 cm; II Exophytic, mucoepidermoid carcinoma, grade 3, HPV− Wide resection; radiation A, NED, no recurrences, 1.2 year
20 52 W M L; S Y: 29 mo before 14 mo; mass 1.0 cm; I Inverted, SCC, grade 1, HPV− Wide resection A, NED, no recurrences, 2.5 year

HPV human papillomavirus, F Female, M Male, B Black, W White, L Left, R Right, Bi Bilateral, NC Nasal cavity, F Frontal, S Sphenoid, Ma Maxillary sinus, E Ethmoid, NP Nasopharynx, mo months, SCC Squamous cell carcinoma, Gy Gray, A Alive, D Dead, NED no evidence of disease, LD local disease, yr years, SNUC Sinonasal undifferentiated carcinoma, FESS Functional endoscopic sinus surgery, LN lymph node metastasis